BMS-986405 is a small molecule Gamma-Secretase Inhibitor being investigated in clinical trials in patients with T-cell acute lymphoblastic leukemia, T-cell lymphoblastic lymphoma and multiple myeloma.
| SparkCures ID | 313 |
|---|---|
| Developed By | Eli Lilly and Company |
| Generic Name | BMS-986405 |
| Additional Names | LY3039478, JSMD194 |
| Treatment Classifications |
|
There are no resources, links or videos to display for this treatment.